In:

Our partners at Zalgen recently received the exciting news that the FDA has completed the transfer of Emergency Use Authorization for…
Read more
We were pleased to have Circa reporter Daniel Bean to our facility last month. We gave him a tour of the…
Read more
Published on November 3, 2016 by Global Biodefense: News on Pathogens and Preparadness “Zalgen Labs recently announced that it has entered…
Read more
Written by Joe Buercklin of AMP “Zalgen Labs LLC, a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, announced that it…
Read more